State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 310000, Hangzhou, China.
Zhejiang Provincial Peoples's Hospital, 310000, Hangzhou, China.
BMC Public Health. 2023 Feb 6;23(1):256. doi: 10.1186/s12889-023-15130-y.
This study aimed to estimate hepatitis B incidence and chronicity risk in rural adults in China under the background of eliminating viral hepatitis.
Hepatitis B surface antigen (HBsAg) screening was conducted every 2 years in demonstration areas since 2011. Individuals with baseline HBsAg-negative were included. Incidence was calculated as the number of HBsAg-positive cases divided by the total person-times. HBsAg-positive individuals were followed up to study the persistent infection (> 6 months), chronic infection (> 12 months), and recovery with hepatitis B surface antibody (anti-HBs). The chi-square test and cox proportional regression analysis were performed.
There were 8,942 incident cases over 2,138,532 person-years, yielding an average incidence of 0.42 per 100 person-years. HBV incidence decreased rapidly in both genders and all age groups and then kept stable. Male gender, low population density, low gross domestic product per capita, and islanders were associated with higher incidence. Of the positive cases, 4,989 (55.8%) patients were followed up. The persistent infection, chronic infection, and recovery with anti-HBs rates were 32.3%, 31.0%, and 31.4%, respectively. Persistent or chronic infection was more common in younger adults and males, while seroconversion had no concern with gender or age.
HBV incidence in adult rural residents was decreasing and stayed low. The chronicity rate was relatively high and protective antibodies were induced in only one third. The importance of population-based screening and vaccination for susceptible individuals should be addressed.
本研究旨在估计中国消除病毒性肝炎背景下农村成年人的乙型肝炎发病率和慢性风险。
自 2011 年以来,在示范地区每两年进行一次乙型肝炎表面抗原(HBsAg)筛查。纳入基线 HBsAg 阴性的个体。发病率计算为 HBsAg 阳性病例数除以总人数。对 HBsAg 阳性个体进行随访,以研究持续性感染(>6 个月)、慢性感染(>12 个月)和乙型肝炎表面抗体(抗-HBs)恢复情况。采用卡方检验和 cox 比例风险回归分析。
共发生 8942 例新发病例,累计 2138532 人年,平均发病率为 0.42/100 人年。男女和各年龄组的 HBV 发病率均迅速下降,随后保持稳定。男性、人口密度低、人均国内生产总值低和岛民与较高的发病率相关。在阳性病例中,有 4989 例(55.8%)患者进行了随访。持续性感染、慢性感染和抗-HBs 恢复率分别为 32.3%、31.0%和 31.4%。持续性或慢性感染在年轻成年人和男性中更为常见,而血清转换与性别或年龄无关。
成年农村居民的 HBV 发病率正在下降且保持在较低水平。慢性感染率相对较高,仅有三分之一诱导出保护性抗体。应重视对易感人群进行基于人群的筛查和疫苗接种。